Idorsia Ltd
Idorsia Ltd IDRSF Peers
See (IDRSF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IDRSF | $2.40 | +6.67% | 505.8M | -1.45 | -$1.65 | N/A |
| NONOF | $69.48 | +1.80% | 305.6B | 19.02 | $3.62 | +2.43% |
| CSLLY | $79.20 | +2.78% | 153.2B | 29.08 | $2.72 | +1.67% |
| CMXHF | $163.07 | +6.57% | 79B | 29.92 | $5.45 | +1.70% |
| UCBJY | $98.75 | -0.65% | 37.4B | 31.26 | $3.15 | +0.80% |
| UCBJF | $199.89 | -1.02% | 37.1B | 31.03 | $6.29 | +0.81% |
| ARGNF | $547.18 | -2.64% | 33.4B | 33.32 | $16.42 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $10.33 | +2.48% | 17.1B | -1033.20 | -$0.01 | N/A |
| WXXWY | $6.35 | -0.31% | 13.4B | 29.55 | $0.22 | N/A |
Stock Comparison
IDRSF vs NONOF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, NONOF has a market cap of 305.6B. Regarding current trading prices, IDRSF is priced at $2.40, while NONOF trades at $69.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas NONOF's P/E ratio is 19.02. In terms of profitability, IDRSF's ROE is +0.24%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, IDRSF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs CSLLY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CSLLY has a market cap of 153.2B. Regarding current trading prices, IDRSF is priced at $2.40, while CSLLY trades at $79.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CSLLY's P/E ratio is 29.08. In terms of profitability, IDRSF's ROE is +0.24%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, IDRSF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs CMXHF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CMXHF has a market cap of 79B. Regarding current trading prices, IDRSF is priced at $2.40, while CMXHF trades at $163.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CMXHF's P/E ratio is 29.92. In terms of profitability, IDRSF's ROE is +0.24%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, IDRSF and CMXHF have similar daily volatility (0.00).
IDRSF vs UCBJY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, UCBJY has a market cap of 37.4B. Regarding current trading prices, IDRSF is priced at $2.40, while UCBJY trades at $98.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas UCBJY's P/E ratio is 31.26. In terms of profitability, IDRSF's ROE is +0.24%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, IDRSF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs UCBJF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, UCBJF has a market cap of 37.1B. Regarding current trading prices, IDRSF is priced at $2.40, while UCBJF trades at $199.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas UCBJF's P/E ratio is 31.03. In terms of profitability, IDRSF's ROE is +0.24%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, IDRSF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ARGNF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ARGNF has a market cap of 33.4B. Regarding current trading prices, IDRSF is priced at $2.40, while ARGNF trades at $547.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ARGNF's P/E ratio is 33.32. In terms of profitability, IDRSF's ROE is +0.24%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, IDRSF is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ODTC Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, IDRSF is priced at $2.40, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ODTC's P/E ratio is 1.07. In terms of profitability, IDRSF's ROE is +0.24%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, IDRSF and ODTC have similar daily volatility (0.00).
IDRSF vs IVBXF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, IVBXF has a market cap of 17.1B. Regarding current trading prices, IDRSF is priced at $2.40, while IVBXF trades at $10.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas IVBXF's P/E ratio is -1033.20. In terms of profitability, IDRSF's ROE is +0.24%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, IDRSF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs WXXWY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, WXXWY has a market cap of 13.4B. Regarding current trading prices, IDRSF is priced at $2.40, while WXXWY trades at $6.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas WXXWY's P/E ratio is 29.55. In terms of profitability, IDRSF's ROE is +0.24%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, IDRSF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs GNMSF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, GNMSF has a market cap of 13B. Regarding current trading prices, IDRSF is priced at $2.40, while GNMSF trades at $211.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas GNMSF's P/E ratio is 12.41. In terms of profitability, IDRSF's ROE is +0.24%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, IDRSF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs WXIBF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, WXIBF has a market cap of 12.9B. Regarding current trading prices, IDRSF is priced at $2.40, while WXIBF trades at $3.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas WXIBF's P/E ratio is 28.91. In terms of profitability, IDRSF's ROE is +0.24%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, IDRSF and WXIBF have similar daily volatility (0.00).
IDRSF vs SBMFF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SBMFF has a market cap of 12.4B. Regarding current trading prices, IDRSF is priced at $2.40, while SBMFF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SBMFF's P/E ratio is 69.26. In terms of profitability, IDRSF's ROE is +0.24%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, IDRSF and SBMFF have similar daily volatility (0.00).
IDRSF vs SBHMY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SBHMY has a market cap of 8.7B. Regarding current trading prices, IDRSF is priced at $2.40, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SBHMY's P/E ratio is 33.62. In terms of profitability, IDRSF's ROE is +0.24%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, IDRSF and SBHMY have similar daily volatility (0.00).
IDRSF vs TRSBF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, TRSBF has a market cap of 7.7B. Regarding current trading prices, IDRSF is priced at $2.40, while TRSBF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas TRSBF's P/E ratio is 27.08. In terms of profitability, IDRSF's ROE is +0.24%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, IDRSF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs TLPPF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, TLPPF has a market cap of 5.4B. Regarding current trading prices, IDRSF is priced at $2.40, while TLPPF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas TLPPF's P/E ratio is 177.78. In terms of profitability, IDRSF's ROE is +0.24%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, IDRSF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ABCZF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, IDRSF is priced at $2.40, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, IDRSF's ROE is +0.24%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, IDRSF and ABCZF have similar daily volatility (0.00).
IDRSF vs AKBLF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, AKBLF has a market cap of 5B. Regarding current trading prices, IDRSF is priced at $2.40, while AKBLF trades at $22.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas AKBLF's P/E ratio is 33.86. In terms of profitability, IDRSF's ROE is +0.24%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, IDRSF and AKBLF have similar daily volatility (0.00).
IDRSF vs INCPF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, IDRSF is priced at $2.40, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas INCPF's P/E ratio is -108.67. In terms of profitability, IDRSF's ROE is +0.24%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, IDRSF and INCPF have similar daily volatility (0.00).
IDRSF vs LABFF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, IDRSF is priced at $2.40, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas LABFF's P/E ratio is 28.95. In terms of profitability, IDRSF's ROE is +0.24%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, IDRSF and LABFF have similar daily volatility (0.00).
IDRSF vs GNNSF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, GNNSF has a market cap of 4.5B. Regarding current trading prices, IDRSF is priced at $2.40, while GNNSF trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas GNNSF's P/E ratio is -25.87. In terms of profitability, IDRSF's ROE is +0.24%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, IDRSF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ZLDPF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ZLDPF has a market cap of 4.1B. Regarding current trading prices, IDRSF is priced at $2.40, while ZLDPF trades at $57.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ZLDPF's P/E ratio is -21.38. In terms of profitability, IDRSF's ROE is +0.24%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, IDRSF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs REGMF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, IDRSF is priced at $2.40, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas REGMF's P/E ratio is -13.32. In terms of profitability, IDRSF's ROE is +0.24%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, IDRSF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs CAMRF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CAMRF has a market cap of 3.4B. Regarding current trading prices, IDRSF is priced at $2.40, while CAMRF trades at $56.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CAMRF's P/E ratio is 58.30. In terms of profitability, IDRSF's ROE is +0.24%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, IDRSF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs GLPGF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, GLPGF has a market cap of 3.2B. Regarding current trading prices, IDRSF is priced at $2.40, while GLPGF trades at $48.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas GLPGF's P/E ratio is -15.56. In terms of profitability, IDRSF's ROE is +0.24%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, IDRSF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs TKBIF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, IDRSF is priced at $2.40, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, IDRSF's ROE is +0.24%, compared to TKBIF's ROE of N/A. Regarding short-term risk, IDRSF and TKBIF have similar daily volatility (0.00).
IDRSF vs MPSYF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, IDRSF is priced at $2.40, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, IDRSF's ROE is +0.24%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, IDRSF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ASPHF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, IDRSF is priced at $2.40, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, IDRSF's ROE is +0.24%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, IDRSF is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs BVNKF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, IDRSF is priced at $2.40, while BVNKF trades at $26.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BVNKF's P/E ratio is 10.34. In terms of profitability, IDRSF's ROE is +0.24%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, IDRSF and BVNKF have similar daily volatility (0.00).
IDRSF vs BVNRY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BVNRY has a market cap of 2.1B. Regarding current trading prices, IDRSF is priced at $2.40, while BVNRY trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BVNRY's P/E ratio is 10.24. In terms of profitability, IDRSF's ROE is +0.24%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, IDRSF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs SHJBF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SHJBF has a market cap of 2B. Regarding current trading prices, IDRSF is priced at $2.40, while SHJBF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SHJBF's P/E ratio is -7.22. In terms of profitability, IDRSF's ROE is +0.24%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, IDRSF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs BTTAY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, IDRSF is priced at $2.40, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, IDRSF's ROE is +0.24%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, IDRSF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ONTTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, IDRSF is priced at $2.40, while ONTTF trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ONTTF's P/E ratio is -8.67. In terms of profitability, IDRSF's ROE is +0.24%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, IDRSF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs GENSF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, IDRSF is priced at $2.40, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas GENSF's P/E ratio is -325.12. In terms of profitability, IDRSF's ROE is +0.24%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, IDRSF and GENSF have similar daily volatility (0.00).
IDRSF vs PHMMF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, IDRSF is priced at $2.40, while PHMMF trades at $92.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PHMMF's P/E ratio is 72.88. In terms of profitability, IDRSF's ROE is +0.24%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, IDRSF and PHMMF have similar daily volatility (0.00).
IDRSF vs BRCTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, IDRSF is priced at $2.40, while BRCTF trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BRCTF's P/E ratio is 18.10. In terms of profitability, IDRSF's ROE is +0.24%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, IDRSF and BRCTF have similar daily volatility (0.00).
IDRSF vs BIESF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BIESF has a market cap of 1.7B. Regarding current trading prices, IDRSF is priced at $2.40, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BIESF's P/E ratio is -44.44. In terms of profitability, IDRSF's ROE is +0.24%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, IDRSF and BIESF have similar daily volatility (0.00).
IDRSF vs PPTDF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PPTDF has a market cap of 1.5B. Regarding current trading prices, IDRSF is priced at $2.40, while PPTDF trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PPTDF's P/E ratio is 14.94. In terms of profitability, IDRSF's ROE is +0.24%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, IDRSF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs CSBTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, IDRSF is priced at $2.40, while CSBTF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CSBTF's P/E ratio is -291.67. In terms of profitability, IDRSF's ROE is +0.24%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, IDRSF is less volatile compared to CSBTF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs BRAXF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, IDRSF is priced at $2.40, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, IDRSF's ROE is +0.24%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, IDRSF is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs MEOBF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, IDRSF is priced at $2.40, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas MEOBF's P/E ratio is -16.08. In terms of profitability, IDRSF's ROE is +0.24%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, IDRSF and MEOBF have similar daily volatility (0.00).
IDRSF vs NURPF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, IDRSF is priced at $2.40, while NURPF trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas NURPF's P/E ratio is 12.41. In terms of profitability, IDRSF's ROE is +0.24%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, IDRSF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ASCLF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ASCLF has a market cap of 900.1M. Regarding current trading prices, IDRSF is priced at $2.40, while ASCLF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ASCLF's P/E ratio is -23.21. In terms of profitability, IDRSF's ROE is +0.24%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, IDRSF and ASCLF have similar daily volatility (0.00).
IDRSF vs PHGUF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PHGUF has a market cap of 782.4M. Regarding current trading prices, IDRSF is priced at $2.40, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, IDRSF's ROE is +0.24%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, IDRSF and PHGUF have similar daily volatility (0.00).
IDRSF vs HBMHF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, HBMHF has a market cap of 766.2M. Regarding current trading prices, IDRSF is priced at $2.40, while HBMHF trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas HBMHF's P/E ratio is 30.16. In terms of profitability, IDRSF's ROE is +0.24%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, IDRSF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs BPMUF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BPMUF has a market cap of 636.8M. Regarding current trading prices, IDRSF is priced at $2.40, while BPMUF trades at $51.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BPMUF's P/E ratio is 7.30. In terms of profitability, IDRSF's ROE is +0.24%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, IDRSF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs SOLTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SOLTF has a market cap of 597.3M. Regarding current trading prices, IDRSF is priced at $2.40, while SOLTF trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SOLTF's P/E ratio is -36.67. In terms of profitability, IDRSF's ROE is +0.24%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, IDRSF and SOLTF have similar daily volatility (0.00).
IDRSF vs INRLF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, IDRSF is priced at $2.40, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas INRLF's P/E ratio is -5.08. In terms of profitability, IDRSF's ROE is +0.24%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, IDRSF and INRLF have similar daily volatility (0.00).
IDRSF vs IVEVF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, IVEVF has a market cap of 506.3M. Regarding current trading prices, IDRSF is priced at $2.40, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, IDRSF's ROE is +0.24%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, IDRSF and IVEVF have similar daily volatility (0.00).
IDRSF vs OXBOF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, OXBOF has a market cap of 489.4M. Regarding current trading prices, IDRSF is priced at $2.40, while OXBOF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas OXBOF's P/E ratio is -4.17. In terms of profitability, IDRSF's ROE is +0.24%, compared to OXBOF's ROE of -2.22%. Regarding short-term risk, IDRSF is less volatile compared to OXBOF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs CKDXF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CKDXF has a market cap of 482.4M. Regarding current trading prices, IDRSF is priced at $2.40, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, IDRSF's ROE is +0.24%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, IDRSF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs VBIZF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, VBIZF has a market cap of 472.2M. Regarding current trading prices, IDRSF is priced at $2.40, while VBIZF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas VBIZF's P/E ratio is 22.70. In terms of profitability, IDRSF's ROE is +0.24%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, IDRSF and VBIZF have similar daily volatility (0.00).
IDRSF vs SNBIF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SNBIF has a market cap of 471.7M. Regarding current trading prices, IDRSF is priced at $2.40, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, IDRSF's ROE is +0.24%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, IDRSF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs AAVXF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, AAVXF has a market cap of 457.5M. Regarding current trading prices, IDRSF is priced at $2.40, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas AAVXF's P/E ratio is -2.09. In terms of profitability, IDRSF's ROE is +0.24%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, IDRSF and AAVXF have similar daily volatility (0.00).
IDRSF vs RAONF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, IDRSF is priced at $2.40, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas RAONF's P/E ratio is -43.33. In terms of profitability, IDRSF's ROE is +0.24%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, IDRSF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs BXPHF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BXPHF has a market cap of 451M. Regarding current trading prices, IDRSF is priced at $2.40, while BXPHF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BXPHF's P/E ratio is -23.00. In terms of profitability, IDRSF's ROE is +0.24%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, IDRSF and BXPHF have similar daily volatility (0.00).
IDRSF vs BOVNF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BOVNF has a market cap of 436.3M. Regarding current trading prices, IDRSF is priced at $2.40, while BOVNF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BOVNF's P/E ratio is -8.96. In terms of profitability, IDRSF's ROE is +0.24%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, IDRSF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs CSPHF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CSPHF has a market cap of 435.6M. Regarding current trading prices, IDRSF is priced at $2.40, while CSPHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CSPHF's P/E ratio is -32.10. In terms of profitability, IDRSF's ROE is +0.24%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, IDRSF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs TBGNF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, IDRSF is priced at $2.40, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, IDRSF's ROE is +0.24%, compared to TBGNF's ROE of N/A. Regarding short-term risk, IDRSF and TBGNF have similar daily volatility (0.00).
IDRSF vs PTCHF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PTCHF has a market cap of 396.8M. Regarding current trading prices, IDRSF is priced at $2.40, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PTCHF's P/E ratio is 7.87. In terms of profitability, IDRSF's ROE is +0.24%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, IDRSF and PTCHF have similar daily volatility (0.00).
IDRSF vs CLVLF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CLVLF has a market cap of 361.9M. Regarding current trading prices, IDRSF is priced at $2.40, while CLVLF trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CLVLF's P/E ratio is 14.44. In terms of profitability, IDRSF's ROE is +0.24%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, IDRSF and CLVLF have similar daily volatility (0.00).
IDRSF vs HLOSF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, HLOSF has a market cap of 340.2M. Regarding current trading prices, IDRSF is priced at $2.40, while HLOSF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas HLOSF's P/E ratio is -10.48. In terms of profitability, IDRSF's ROE is +0.24%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, IDRSF and HLOSF have similar daily volatility (0.00).
IDRSF vs CYDY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CYDY has a market cap of 339.9M. Regarding current trading prices, IDRSF is priced at $2.40, while CYDY trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CYDY's P/E ratio is -13.79. In terms of profitability, IDRSF's ROE is +0.24%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, IDRSF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs NWBO Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, NWBO has a market cap of 335.4M. Regarding current trading prices, IDRSF is priced at $2.40, while NWBO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas NWBO's P/E ratio is -3.88. In terms of profitability, IDRSF's ROE is +0.24%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, IDRSF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs PRRUF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PRRUF has a market cap of 322.9M. Regarding current trading prices, IDRSF is priced at $2.40, while PRRUF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PRRUF's P/E ratio is -11.05. In terms of profitability, IDRSF's ROE is +0.24%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, IDRSF and PRRUF have similar daily volatility (0.00).
IDRSF vs CLVLY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CLVLY has a market cap of 317.3M. Regarding current trading prices, IDRSF is priced at $2.40, while CLVLY trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CLVLY's P/E ratio is 12.64. In terms of profitability, IDRSF's ROE is +0.24%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, IDRSF and CLVLY have similar daily volatility (0.00).
IDRSF vs PBBIF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, IDRSF is priced at $2.40, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, IDRSF's ROE is +0.24%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, IDRSF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs GNFTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, GNFTF has a market cap of 276.3M. Regarding current trading prices, IDRSF is priced at $2.40, while GNFTF trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas GNFTF's P/E ratio is 13.87. In terms of profitability, IDRSF's ROE is +0.24%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, IDRSF and GNFTF have similar daily volatility (0.00).
IDRSF vs PRNAF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PRNAF has a market cap of 276.2M. Regarding current trading prices, IDRSF is priced at $2.40, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, IDRSF's ROE is +0.24%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, IDRSF and PRNAF have similar daily volatility (0.00).
IDRSF vs CLTEF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CLTEF has a market cap of 267.4M. Regarding current trading prices, IDRSF is priced at $2.40, while CLTEF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CLTEF's P/E ratio is -3.74. In terms of profitability, IDRSF's ROE is +0.24%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, IDRSF is less volatile compared to CLTEF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs AVCTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, AVCTF has a market cap of 241M. Regarding current trading prices, IDRSF is priced at $2.40, while AVCTF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas AVCTF's P/E ratio is -5.19. In terms of profitability, IDRSF's ROE is +0.24%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, IDRSF and AVCTF have similar daily volatility (0.00).
IDRSF vs OPORF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, OPORF has a market cap of 240.5M. Regarding current trading prices, IDRSF is priced at $2.40, while OPORF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas OPORF's P/E ratio is 17.50. In terms of profitability, IDRSF's ROE is +0.24%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, IDRSF and OPORF have similar daily volatility (0.00).
IDRSF vs ORYZF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, IDRSF is priced at $2.40, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ORYZF's P/E ratio is -50.50. In terms of profitability, IDRSF's ROE is +0.24%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, IDRSF and ORYZF have similar daily volatility (0.00).
IDRSF vs NWPHF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, IDRSF is priced at $2.40, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas NWPHF's P/E ratio is N/A. In terms of profitability, IDRSF's ROE is +0.24%, compared to NWPHF's ROE of N/A. Regarding short-term risk, IDRSF and NWPHF have similar daily volatility (0.00).
IDRSF vs MDCLF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, IDRSF is priced at $2.40, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, IDRSF's ROE is +0.24%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, IDRSF is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs SLNCF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, IDRSF is priced at $2.40, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, IDRSF's ROE is +0.24%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, IDRSF is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs SPHDF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SPHDF has a market cap of 211.8M. Regarding current trading prices, IDRSF is priced at $2.40, while SPHDF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SPHDF's P/E ratio is -3.66. In terms of profitability, IDRSF's ROE is +0.24%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, IDRSF and SPHDF have similar daily volatility (0.00).
IDRSF vs FPHAF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, IDRSF is priced at $2.40, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, IDRSF's ROE is +0.24%, compared to FPHAF's ROE of N/A. Regarding short-term risk, IDRSF and FPHAF have similar daily volatility (0.00).
IDRSF vs BSEM Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BSEM has a market cap of 208.3M. Regarding current trading prices, IDRSF is priced at $2.40, while BSEM trades at $12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BSEM's P/E ratio is -22.37. In terms of profitability, IDRSF's ROE is +0.24%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, IDRSF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs VSBC Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, IDRSF is priced at $2.40, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas VSBC's P/E ratio is N/A. In terms of profitability, IDRSF's ROE is +0.24%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, IDRSF and VSBC have similar daily volatility (0.00).
IDRSF vs FGHQF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, IDRSF is priced at $2.40, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, IDRSF's ROE is +0.24%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, IDRSF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs HNSBF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, HNSBF has a market cap of 203.4M. Regarding current trading prices, IDRSF is priced at $2.40, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, IDRSF's ROE is +0.24%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, IDRSF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs BRIBF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, BRIBF has a market cap of 190.3M. Regarding current trading prices, IDRSF is priced at $2.40, while BRIBF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas BRIBF's P/E ratio is -2.60. In terms of profitability, IDRSF's ROE is +0.24%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, IDRSF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs CMVLF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, CMVLF has a market cap of 187.4M. Regarding current trading prices, IDRSF is priced at $2.40, while CMVLF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas CMVLF's P/E ratio is -3.88. In terms of profitability, IDRSF's ROE is +0.24%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, IDRSF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs NGENF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, NGENF has a market cap of 182.9M. Regarding current trading prices, IDRSF is priced at $2.40, while NGENF trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas NGENF's P/E ratio is -8.97. In terms of profitability, IDRSF's ROE is +0.24%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, IDRSF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs IPHYF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, IPHYF has a market cap of 179.7M. Regarding current trading prices, IDRSF is priced at $2.40, while IPHYF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas IPHYF's P/E ratio is -2.79. In terms of profitability, IDRSF's ROE is +0.24%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, IDRSF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ADOCY Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, IDRSF is priced at $2.40, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, IDRSF's ROE is +0.24%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, IDRSF and ADOCY have similar daily volatility (0.00).
IDRSF vs MLLCF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, IDRSF is priced at $2.40, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas MLLCF's P/E ratio is -1.99. In terms of profitability, IDRSF's ROE is +0.24%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, IDRSF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs RECEF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, RECEF has a market cap of 144.2M. Regarding current trading prices, IDRSF is priced at $2.40, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas RECEF's P/E ratio is -8.33. In terms of profitability, IDRSF's ROE is +0.24%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, IDRSF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs SCNLF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, SCNLF has a market cap of 135.3M. Regarding current trading prices, IDRSF is priced at $2.40, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas SCNLF's P/E ratio is -4.35. In terms of profitability, IDRSF's ROE is +0.24%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, IDRSF and SCNLF have similar daily volatility (0.00).
IDRSF vs AAPGV Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, IDRSF is priced at $2.40, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas AAPGV's P/E ratio is N/A. In terms of profitability, IDRSF's ROE is +0.24%, compared to AAPGV's ROE of N/A. Regarding short-term risk, IDRSF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs AMGXF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, AMGXF has a market cap of 127.1M. Regarding current trading prices, IDRSF is priced at $2.40, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, IDRSF's ROE is +0.24%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, IDRSF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs PSTTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, IDRSF is priced at $2.40, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, IDRSF's ROE is +0.24%, compared to PSTTF's ROE of N/A. Regarding short-term risk, IDRSF and PSTTF have similar daily volatility (0.00).
IDRSF vs EPRXF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, IDRSF is priced at $2.40, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, IDRSF's ROE is +0.24%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, IDRSF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ADOIF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, IDRSF is priced at $2.40, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, IDRSF's ROE is +0.24%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, IDRSF and ADOIF have similar daily volatility (0.00).
IDRSF vs JWCTF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, IDRSF is priced at $2.40, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, IDRSF's ROE is +0.24%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, IDRSF and JWCTF have similar daily volatility (0.00).
IDRSF vs TRGNF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, TRGNF has a market cap of 92.4M. Regarding current trading prices, IDRSF is priced at $2.40, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, IDRSF's ROE is +0.24%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, IDRSF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs MCURF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, IDRSF is priced at $2.40, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas MCURF's P/E ratio is -16.90. In terms of profitability, IDRSF's ROE is +0.24%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, IDRSF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs ACHFF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, ACHFF has a market cap of 85.9M. Regarding current trading prices, IDRSF is priced at $2.40, while ACHFF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas ACHFF's P/E ratio is -43.33. In terms of profitability, IDRSF's ROE is +0.24%, compared to ACHFF's ROE of +0.53%. Regarding short-term risk, IDRSF is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for IDRSF.
IDRSF vs PBIGF Comparison
IDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IDRSF stands at 505.8M. In comparison, PBIGF has a market cap of 84.4M. Regarding current trading prices, IDRSF is priced at $2.40, while PBIGF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IDRSF currently has a P/E ratio of -1.45, whereas PBIGF's P/E ratio is -7.22. In terms of profitability, IDRSF's ROE is +0.24%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, IDRSF and PBIGF have similar daily volatility (0.00).